Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Jennifer L Vande Voort"'
Autor:
Deniz Yuruk, Can Ozger, Juan F Garzon, Jarrod M Leffler, Julia Shekunov, Jennifer L Vande Voort, Michael J Zaccariello, Paul A Nakonezny, Paul E Croarkin
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0280010 (2023)
BackgroundSuicide is a leading cause of death in adolescents worldwide. Previous research findings suggest that suicidal adolescents with depression have pathophysiological dorsolateral prefrontal cortex (DLPFC) deficits in γ-aminobutyric acid neuro
Externí odkaz:
https://doaj.org/article/e42755f397354e8b8f355c5a29af8c0e
Autor:
Julia Shekunov, Caren J. Blacker, Jennifer L. Vande Voort, Jan-Mendelt Tillema, Paul E. Croarkin, Magdalena Romanowicz
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Autoimmune encephalitis is characterized by neuropsychiatric symptoms associated with brain inflammation. The differential is usually broad and Psychiatry often collaborates with Neurology in diagnostic clarification and symptom m
Externí odkaz:
https://doaj.org/article/519fbca9ea1c4b87b625705efd041ac4
Autor:
Balwinder Singh, Jennifer L. Vande Voort, Patricio Riva-Posse, Vanessa M. Pazdernik, Mark A. Frye, Susannah J. Tye
Publikováno v:
Biological Psychiatry. 93:e65-e68
Autor:
Parmis Fatih, M. Utku Kucuker, Jennifer L. Vande Voort, Deniz Doruk Camsari, Faranak Farzan, Paul E. Croarkin
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Long-interval intracortical inhibition (LICI) is a paired-pulse transcranial magnetic stimulation (TMS) paradigm mediated in part by gamma-aminobutyric acid receptor B (GABAB) inhibition. Prior work has examined LICI as a putative biomarker in an arr
Externí odkaz:
https://doaj.org/article/be6d9d589a81490b983f98d3f1be34e4
Autor:
Magdalena Romanowicz, Jennifer L. Vande Voort, Julia Shekunov, Tyler S. Oesterle, Nuria J. Thusius, Teresa A. Rummans, Paul E. Croarkin, Victor M. Karpyak, Brian A. Lynch, Kathryn M. Schak
Publikováno v:
Child and Adolescent Psychiatry and Mental Health, Vol 13, Iss 1, Pp 1-11 (2019)
Abstract Background Between 2009 and 2014, nearly 3% of US children (age ≤ 17 years) lived in households with at least 1 parent with substance use disorder. The present systematic review aimed to evaluate effects of parental opioid use disorder on
Externí odkaz:
https://doaj.org/article/7431a35b046b458985110394680a87bd
Autor:
Adrienne Lapidos, Daniela Lopez-Vives, Cortney E. Sera, Elizabeth Ahearn, Erica Vest, Ivana Senic, Jennifer L. Vande Voort, Mark Frye, Fernando S. Goes, Eric Achtyes, John Greden, Sagar V. Parikh
Publikováno v:
Journal of Affective Disorders. 323:534-539
Intravenous (IV) ketamine is an effective therapy for treatment-resistant depression. A large data base is confirmatory and steadily expanding. Qualitative studies can inform best practices and suggest new research directions. As part of a clinical t
Autor:
Ewa D. Bieber, Gail A. Edelsohn, Maria E. McGee, Julia Shekunov, Magdalena Romanowicz, Jennifer L. Vande Voort, Alastair J. S. McKean
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
Introduction: Parents/legal guardians are medical decision-makers for their minor children. Lack of parental capacity to appreciate the implications of the diagnosis and consequences of refusing recommended treatment may impede pediatric patients fro
Externí odkaz:
https://doaj.org/article/e0d4eed3949c4a248801fa3092184f6c
Autor:
Rakesh Kumar, Juan Garzon, Deniz Yuruk, Leslie C. Hassett, Maria Saliba, Can Ozger, Cinar Oztosun, Kelly Ahern, Arjun P. Athreya, Balwinder Singh, Paul E. Croarkin, Jennifer L. Vande Voort
Publikováno v:
Acta Psychiatrica Scandinavica. 147:248-256
To appraise the current evidence on the efficacy and safety of lamotrigine (LAM) in the treatment of pediatric mood disorders (PMD) (i.e., Major Depressive disorder [MDD], bipolar disorder [BD]).Major databases were searched for randomized controlled
Autor:
Carl Y. Zhang, Jennifer L. Vande Voort, Deniz Yuruk, Jeffrey A. Mills, Graham J. Emslie, Betsy D. Kennard, Taryn Mayes, Madhukar Trivedi, William V. Bobo, Jeffrey R. Strawn, Arjun P. Athreya, Paul E. Croarkin
Publikováno v:
J Child Adolesc Psychopharmacol
INTRODUCTION: The Clinical Global Impressions-Improvement (CGI-I) scale is widely used in clinical research to assess symptoms and functioning in the context of treatment. The correlates of the CGI-I with efficacy scales for adolescent major depressi
Autor:
Marin Veldic, Ahmed T. Ahmed, Caren J. Blacker, Jennifer R. Geske, Joanna M. Biernacka, Kristin L. Borreggine, Katherine M. Moore, Miguel L. Prieto, Jennifer L. Vande Voort, Paul E. Croarkin, Astrid A. Hoberg, Simon Kung, Renato D. Alarcon, Nicola Keeth, Balwinder Singh, William V. Bobo, Mark A. Frye
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Background: Pharmacogenomic testing, specifically for pharmacokinetic (PK) and pharmacodynamic (PD) genetic variation, may contribute to a better understanding of baseline genetic differences in patients seeking treatment for depression, which may fu
Externí odkaz:
https://doaj.org/article/39bb551daf2f485885d47192dd557e52